首页> 外文期刊>Clinical investigation >Drug-eluting balloons: where are we and what are the problems?
【24h】

Drug-eluting balloons: where are we and what are the problems?

机译:药物洗脱气球:我们在哪里?问题在哪里?

获取原文
获取原文并翻译 | 示例
           

摘要

The starting point of percutaneous transluminal coronary angioplasty was defined by Andreas Griintzig in 1977 [l]. He developed the novel technique of revascularization and established a new speciality - interventional cardiology.Since that time, interventionalists have been confronted with the problems of vessel recoil during the procedure and restenosis within the first 6 months of balloon angioplasty. In spite of progress in some indications, in others these challenges have lost nothing of their significance, motivating investigators to pursue their research efforts with a view to finding new strategies for overcoming these difficulties.
机译:1977年Andreas Griintzig定义了经皮腔内冠状动脉成形术的起点[1]。他开发了新的血运重建技术,并建立了一个新的专业-介入心脏病学。从那时起,介入治疗人员就面临着在球囊血管成形术的前6个月过程中血管回缩和再狭窄的问题。尽管在某些适应症方面取得了进展,但在另一些适应症中,这些挑战却丝毫没有失去意义,这促使研究人员继续进行研究工作,以期找到克服这些困难的新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号